Johnson and Johnson seeks nod for vaccine trials on 12-17 age group

20 Aug 2021
5 min read

News Synopsis

The vaccination process is ongoing, and even after all this we still have a long way to go. With only 13% of the total population fully vaccinated, it will be a long process for India to get the whole India vaccinated. More vaccines getting approval in India shows a positive sign towards this. Recently the Jonson and Jonson vaccine got approval in India under Emergency Use Authorization. The vaccine is a single dose vaccine and can help India speed up the vaccination process.

With Johnson and Johnson seeking trials on children for the vaccines, is an initiation towards having vaccines for children as well. With the schools reopening all over India, it is required to have the vaccine as soon as we can. Because even after taking all the precautions India can still face a hard time if the cases spike up again. If Johnson and Johnson single dose vaccine trials are successful, India will be able to vaccinate the children of India as well.


TWN Opinion